Lockport Memorial Hospital closing in on opening day
Lockport Memorial Hospital, a campus of Mount St. Mary’s Hospital, is on track for an Oct. 10 opening of its Emergency Department and in-patient rooms.
Source: niagara-gazette.com
Deb Holliday News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Deb Holliday. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Deb Holliday Today - Breaking & Trending Today
Closing in on opening day
Lockport Memorial Hospital, a campus of Mount St. Mary’s Hospital, is on track for an Oct. 10 opening of its Emergency Department and in-patient rooms.
Source: lockportjournal.com
Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE® (Cyclosporine Ophthalmic Solution) 0.1
VEVYE® is the First and Only Cyclosporine-Based Product Indicated for the Treatment of Both Signs and Symptoms of Dry Eye Disease with Efficacy Demonstrated After Four WeeksVEVYE® is the Only Water-Free Ophthalmic Product with Convenient Twice-Daily (BID) DosingNASHVILLE, Tenn. & HEIDELBERG, Germany--(BUSINESS WIRE)...
Source: pharmiweb.com
Harrow Acquires Santen's Branded Ophthalmic Portfolio
Transaction Includes U.S. and Canadian Commercial Rights to FLAREX®, NATACYN®, TOBRADEX® ST, VERKAZIA®, ZERVIATE®, and Non-Prescription Brands FRESHKOTE® and Cationorm® PLUSNASHVILLE, Tenn.--(BUSINESS WIRE)--$HROW--Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the signing of a...
Source: pharmiweb.com
Harrow Sells Non-Ophthalmic Compounding Business
NASHVILLE, Tenn.--(BUSINESS WIRE)--$HROW--Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, today announced the sale of its non‑ophthalmic compounding business to Innovation Compounding Pharmacy, LLC,...
Source: pharmiweb.com